Mark B. Jones

1.4k total citations
29 papers, 1.1k citations indexed

About

Mark B. Jones is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark B. Jones has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark B. Jones's work include Glycosylation and Glycoproteins Research (16 papers), Immune Cell Function and Interaction (8 papers) and Galectins and Cancer Biology (7 papers). Mark B. Jones is often cited by papers focused on Glycosylation and Glycoproteins Research (16 papers), Immune Cell Function and Interaction (8 papers) and Galectins and Cancer Biology (7 papers). Mark B. Jones collaborates with scholars based in United States, United Kingdom and India. Mark B. Jones's co-authors include Brian A. Cobb, Kevin J. Yarema, J. L. Johnson, Srinivasa‐Gopalan Sampathkumar, Sean O. Ryan, Smita Joshi, Ron Orlando, Sidney W. Whiteheart, Joseph T.Y. Lau and Mehrab Nasirikenari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Mark B. Jones

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark B. Jones United States 17 816 374 258 221 101 29 1.1k
Noboru Uchiyama Japan 15 973 1.2× 410 1.1× 287 1.1× 327 1.5× 166 1.6× 35 1.3k
Kathrin Stavenhagen Netherlands 21 993 1.2× 358 1.0× 256 1.0× 296 1.3× 66 0.7× 30 1.2k
Chun‐Ting Yuen United Kingdom 18 789 1.0× 321 0.9× 241 0.9× 192 0.9× 60 0.6× 31 1.1k
Mark Sutton‐Smith United Kingdom 21 1.3k 1.6× 586 1.6× 377 1.5× 201 0.9× 138 1.4× 29 2.0k
Ana Sofía Carvalho Portugal 19 987 1.2× 339 0.9× 112 0.4× 105 0.5× 154 1.5× 69 1.4k
Ganglong Yang China 18 878 1.1× 265 0.7× 157 0.6× 122 0.6× 100 1.0× 57 1.1k
Elena Korchagina Russia 23 980 1.2× 517 1.4× 374 1.4× 216 1.0× 61 0.6× 68 1.7k
Mayumi Ishihara United States 18 728 0.9× 185 0.5× 219 0.8× 105 0.5× 66 0.7× 35 1.1k
Matthew R. Kudelka United States 13 933 1.1× 402 1.1× 310 1.2× 153 0.7× 94 0.9× 23 1.1k
Junko Amano Japan 19 746 0.9× 193 0.5× 251 1.0× 161 0.7× 66 0.7× 38 1.0k

Countries citing papers authored by Mark B. Jones

Since Specialization
Citations

This map shows the geographic impact of Mark B. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Jones more than expected).

Fields of papers citing papers by Mark B. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Jones. The network helps show where Mark B. Jones may publish in the future.

Co-authorship network of co-authors of Mark B. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Jones. A scholar is included among the top collaborators of Mark B. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Jones. Mark B. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Julie Y., et al.. (2020). Disruption of hepatocyte Sialylation drives a T cell-dependent pro-inflammatory immune tone. Glycoconjugate Journal. 37(3). 395–407. 15 indexed citations
2.
Álvarez‐González, Carlos Alfonso, Mark B. Jones, John Hambor, & Brian A. Cobb. (2020). Characterization of Polysaccharide A Response Reveals Interferon Responsive Gene Signature and Immunomodulatory Marker Expression. Frontiers in Immunology. 11. 556813–556813. 30 indexed citations
3.
Jones, Mark B., Carlos Alfonso Álvarez‐González, J. L. Johnson, et al.. (2019). CD45Rb-low effector T cells require IL-4 to induce IL-10 in FoxP3 Tregs and to protect mice from inflammation. PLoS ONE. 14(5). e0216893–e0216893. 12 indexed citations
4.
Jones, Mark B., Alicia A. Cutler, Amanda Mener, et al.. (2019). Cosmc is required for T cell persistence in the periphery. Glycobiology. 29(11). 776–788. 8 indexed citations
5.
Baker, Courtney E., et al.. (2018). Plasma glycomics predict cardiovascular disease in patients with ART‐controlled HIV infections. The FASEB Journal. 33(2). 1852–1859. 10 indexed citations
6.
Jun, Janice, et al.. (2017). T cell-intrinsic TLR2 stimulation promotes IL-10 expression and suppressive activity by CD45RbHi T cells. PLoS ONE. 12(7). e0180688–e0180688. 12 indexed citations
7.
Jones, Mark B., et al.. (2016). B-cell–independent sialylation of IgG. Proceedings of the National Academy of Sciences. 113(26). 7207–7212. 108 indexed citations
8.
Jones, Mark B., Sean O. Ryan, J. L. Johnson, & Brian A. Cobb. (2016). Dendritic cell-specific Mgat2 knockout mice show antigen presentation defects but reveal an unexpected CD11c expression pattern. Glycobiology. 26(9). 1007–1013. 7 indexed citations
9.
Johnson, J. L., Mark B. Jones, & Brian A. Cobb. (2014). Polysaccharide A from the Capsule of Bacteroides fragilis Induces Clonal CD4+ T Cell Expansion. Journal of Biological Chemistry. 290(8). 5007–5014. 55 indexed citations
10.
Jun, Janice, Sylvia B. Kertesy, Mark B. Jones, et al.. (2013). Innate Immune-Directed NF-κB Signaling Requires Site-Specific NEMO Ubiquitination. Cell Reports. 4(2). 352–361. 11 indexed citations
11.
Johnson, J. L., Mark B. Jones, Sean O. Ryan, & Brian A. Cobb. (2013). The regulatory power of glycans and their binding partners in immunity. Trends in Immunology. 34(6). 290–298. 102 indexed citations
12.
Jones, Mark B., Mehrab Nasirikenari, Amit A. Lugade, Yasmin Thanavala, & Joseph T.Y. Lau. (2012). Anti-inflammatory IgG Production Requires Functional P1 Promoter in β-Galactoside α2,6-Sialyltransferase 1 (ST6Gal-1) Gene. Journal of Biological Chemistry. 287(19). 15365–15370. 48 indexed citations
13.
Jones, Mark B., Mehrab Nasirikenari, Feng Li, et al.. (2010). Role for Hepatic and Circulatory ST6Gal-1 Sialyltransferase in Regulating Myelopoiesis. Journal of Biological Chemistry. 285(32). 25009–25017. 36 indexed citations
14.
Sampathkumar, Srinivasa‐Gopalan, et al.. (2006). Metabolic installation of thiols into sialic acid modulates adhesion and stem cell biology. Nature Chemical Biology. 2(3). 149–152. 121 indexed citations
15.
Sampathkumar, Srinivasa‐Gopalan, Mark B. Jones, Michael A. Meledeo, et al.. (2006). Targeting Glycosylation Pathways and the Cell Cycle: Sugar-Dependent Activity of Butyrate-Carbohydrate Cancer Prodrugs. Chemistry & Biology. 13(12). 1265–1275. 47 indexed citations
16.
Sampathkumar, Srinivasa‐Gopalan, Mark B. Jones, & Kevin J. Yarema. (2006). Metabolic expression of thiol-derivatized sialic acids on the cell surface and their quantitative estimation by flow cytometry. Nature Protocols. 1(4). 1840–1851. 30 indexed citations
17.
Kim, Eun Jeong, et al.. (2004). Characterization of the Metabolic Flux and Apoptotic Effects of O-Hydroxyl- and N-Acyl-modified N-Acetylmannosamine Analogs in Jurkat Cells. Journal of Biological Chemistry. 279(18). 18342–18352. 72 indexed citations
18.
Jones, Mark B., et al.. (2004). Characterization of the cellular uptake and metabolic conversion of acetylated N‐acetylmannosamine (ManNAc) analogues to sialic acids. Biotechnology and Bioengineering. 85(4). 394–405. 87 indexed citations
19.
Tong, L., et al.. (2003). Glycosylation Changes as Markers for the Diagnosis and Treatment of Human Disease. Biotechnology and Genetic Engineering Reviews. 20(1). 199–246. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noboru Uchiyama Breakdown of academic impact, for papers by Kathrin Stavenhagen Breakdown of academic impact, for papers by Chun‐Ting Yuen Breakdown of academic impact, for papers by Mark Sutton‐Smith Breakdown of academic impact, for papers by Ana Sofía Carvalho Breakdown of academic impact, for papers by Ganglong Yang Breakdown of academic impact, for papers by Elena Korchagina Breakdown of academic impact, for papers by Mayumi Ishihara Breakdown of academic impact, for papers by Matthew R. Kudelka Breakdown of academic impact, for papers by Junko Amano
Rankless by CCL
2026